|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-11-19
|
|
pubmed:abstractText |
CCR5Delta32 is a deletion mutation in the chemokine receptor CCR5. Liver inflammatory activity was found to be significantly reduced (P = 0.005) in Jewish Israeli patients infected with the hepatitis C virus (HCV) carrying the CCR5Delta32 allele. The CCR5Delta32 allele does not alter susceptibility to HCV infection; however, it may play a role in the progression and outcome of the disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0960-7420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
249-52
|
|
pubmed:dateRevised |
2011-6-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15548261-Adult,
pubmed-meshheading:15548261-Aged,
pubmed-meshheading:15548261-Aged, 80 and over,
pubmed-meshheading:15548261-Female,
pubmed-meshheading:15548261-Hepacivirus,
pubmed-meshheading:15548261-Hepatitis C,
pubmed-meshheading:15548261-Heterozygote,
pubmed-meshheading:15548261-Humans,
pubmed-meshheading:15548261-Inflammation,
pubmed-meshheading:15548261-Liver,
pubmed-meshheading:15548261-Male,
pubmed-meshheading:15548261-Middle Aged,
pubmed-meshheading:15548261-Mutation,
pubmed-meshheading:15548261-Receptors, CCR5
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.
|
|
pubmed:affiliation |
Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel.
|
|
pubmed:publicationType |
Journal Article
|
